Ocular sarcoidosis

S Pasadhika, JT Rosenbaum - Clinics in chest medicine, 2015 - chestmed.theclinics.com
Ocular involvement of sarcoidosis has been known since the early 1900s and has become
more recognized since the mid-1900s. 1 Variability in the diagnostic criteria has made …

Understanding uveitis: the impact of research on visual outcomes

MD de Smet, SRJ Taylor, B Bodaghi… - Progress in retinal and …, 2011 - Elsevier
The term uveitis encompasses a very diverse group of inflammatory ocular diseases that
cause a significant burden of legal and economic blindness. Indeed, the socioeconomic …

Immunosuppression for the Uveitides

DA Jabs - Ophthalmology, 2018 - Elsevier
The uveitides are a collection of more than 30 diseases characterized by intraocular
inflammation. Many cases of juvenile idiopathic arthritis–associated uveitis, many cases of …

The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management

CS Foster, S Kothari, SD Anesi, AT Vitale, D Chu… - Survey of …, 2016 - Elsevier
Ocular inflammatory disease is a leading cause of vision loss worldwide. Uveitis
encompasses a wide spectrum of pathology, both with respect to its etiology and the …

Effect of corticosteroid-sparing treatment with mycophenolate mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial

SR Rathinam, JA Gonzales, R Thundikandy… - Jama, 2019 - jamanetwork.com
Importance Methotrexate and mycophenolate mofetil are commonly used
immunomodulatory therapies for achieving corticosteroid-sparing control of noninfectious …

Update on the use of systemic biologic agents in the treatment of noninfectious uveitis

S Pasadhika, JT Rosenbaum - Biologics: Targets and Therapy, 2014 - Taylor & Francis
Uveitis is one of the leading causes of blindness worldwide. Noninfectious uveitis may be
associated with other systemic conditions, such as human leukocyte antigen B27-related …

Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye …

AC Gregory II, JH Kempen, E Daniel, RO Kaçmaz… - Ophthalmology, 2013 - Elsevier
PURPOSE: To describe the incidence of and risk factors for visual acuity (VA) loss and
ocular complications in patients with juvenile idiopathic arthritis (JIA)–associated uveitis …

Uveitis for the non-ophthalmologist

BM Burkholder, DA Jabs - Bmj, 2021 - bmj.com
The uveitides are a heterogeneous group of diseases characterized by inflammation inside
the eye. The uveitides are classified as infectious or non-infectious. The non-infectious …

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial

EB Suhler, CY Lowder, DA Goldstein, T Giles… - British Journal of …, 2013 - bjo.bmj.com
Objective Tumour necrosis factor (TNF) blockers have been demonstrated to be effective in
the treatment of systemic and ocular inflammatory diseases. We conducted a prospective …

Recent developments in HLA B27 anterior uveitis

D Wakefield, D Clarke, P McCluskey - Frontiers in Immunology, 2021 - frontiersin.org
There has been steady progress in understanding the pathogenesis, clinical features, and
effective treatment of acute anterior uveitis (AU) over the past 5 years. Large gene wide …